Abstract
Galectins are a family of β-galactoside-binding lectins that are important modulators of homeostasis in the central nervous system (CNS). Galectin-1 is a pivotal regulator of microglia activation that alters the immune balance from neurodegeneration to neuroprotection and could have therapeutic relevance in HIV associated neurocognitive disorders (HAND). We have previously shown that galectin-1 treatment decreased oxidative stress in microglia and hypothesize that the mechanism underlying this phenomenon is the cross regulatory interactions between Nitric oxide (NO) and Arginase I activity in microglia. We induced microglial activation and examined the effect of galectin-1 on the expression of various M1/M2 microglial phenotypic markers. Since, TNF-α is associated with activation of microglial cells involved in pathogenesis of neurodegenerative diseases, we treated HIV transfected human microglial cell cultures (CHME-5/HIV) with TNF-α followed by treatment with galectin-1, to examine the galectin-1 mediated neuro-modulatory response. Our results show that treatment of CHME-5/HIV microglia with galectin-1 reduced TNF-α induced oxidative stress by ~40%, and also significantly reduced iNOS gene expression and NO production while correspondingly increasing arginase-1, cationic amino acid transporter (CAT-1) gene expression and arginase activity. Galectin-1 treatment results in shifting microglia polarization from M1 toward the beneficial M2 phenotype which may prevent neurodegeneration and promote neuroprotection. Thus, our data suggests that galectin-1 treatment reduces neuroinflammation in the CNS microenvironment via the modulation of the NO-arginase network in microglia and thus could play a neuroprotective role in HAND. Further, the therapeutic potential of galectin-1 could be enhanced by conjugation of galectin-1 onto gold nanoparticles (Au-NP), resulting in a nanogold-galectin-1 (Au-Gal-1) multivalent complex that will have more clinical translational efficacy than free galectin-1 by virtue of increasing the payload influx.
Similar content being viewed by others
References
Aalinkeel R, Mahajan SD (2016) Neuroprotective role of galectin-1 in CNS pathophysiology associated with HIV-associated neurocognitive disorders (HAND). Neural regeneration research. Neural Regen Res 11(6):896–897
Almkvist J, Karlsson A (2004) Galectins as inflammatory mediators. Glycoconj J 19:575–581
Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86–92
Barrionuevo P, Beigier-Bompadre M, Ilarregui JM, Toscano MA, Bianco GA, Isturiz MA, Rabinovich GA (2007) A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J Immunol 178:436–445
Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
Borgmann K, Ghorpade A (2015) HIV-1, methamphetamine and astrocytes at neuroinflammatory crossroads. Front Microbiol 6:1143
Boscher C, Dennis JW, Nabi IR (2011) Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol 23:383–392
Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29(1):23–39
Campbell L, Saville CR, Murray PJ, Cruickshank SM, Hardman MJ (2013) Local arginase 1 activity is required for cutaneous wound healing. J Invest Dermatol 133:2461–2470
Chang C, Liao J, Kuo L (1998) Arginase modulates nitric oxide production in activated macrophages. Am J Physiol Heart Circ Physiol 274:342–348
Chang C, Zoghi B, Liao JC, Kuo L (2000) The involvement of tyrosine kinases, cyclic AMP/protein kinase a, and p38 mitogenactivated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J Immunol 165:2134–2141
Chen HL, Liao F, Lin TN, Liu FT (2014) Galectins and neuroinflammation. Adv Neurobiol 9:517–542
Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98
Chicione LG, Stenger MR, Cui H, Calvert A, Evans RJ, Keith English B, Liu Y, Nelin LD (2011) Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells. Am J Phys Lung Cell Mol Phys 300(4):L596–L604
Correa SG, Sotomayor CE, Aoki MP, Maldonado CA, Rabinovich GA (2003) Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages. Glycobiology 13(2):119–128
Cui H, Chen B, Chicoine LG, Nelin LD (2011) Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cells. Clin Exp Pharmacol Physiol 38(12):796–803
Dam TK, Gabius H-J, André S, Kaltner H, Lensch M, Brewer CF (2005) Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 44:12564–12571
Egnaczyk GF, Pomonis JD, Schmidt JA, Rogers SD, Peters C, Ghilardi JR, Mantyh PW, Maggio JE (2003) Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure. Proteomics 3:689–398
Fenn AM, Hall JCE, Gensel JC, Popovich PG, Godbout JP (2014) IL-4 signaling drives a unique arginase+/IL-1β + microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury. J Neurosci 34:8904–8917
Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, Andre S, Gabius HJ, Khachigian L, Detjen KM, Rosewicz S (2005) Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 280:37266–37277
Fischer-Smith T, Rappaport J (2005) Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 7:1–26. doi:10.1017/s1462399405010239
Ghasemi M, Fatemi A (2014) Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases. Neurosci Biobehav Rev 45:168–182
Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755–762
Gray F, Adle-Biassette H, Brion F, Ereau T, le Maner I, Levy V, Corcket G (2000) Neuronal apoptosis in human immunodeficiency virus infection. J Neurovirol 6(Suppl 1):S38–S43
Guang Luo X, Chen SD (2012) The changing phenotype of microglia from homeostasis to disease. Transl Neurosci 1:9. doi:10.1186/2047-9158-1-9
Hanisch UK (2013) Functional diversity of microglia – how heterogeneous are they to begin with? Front Cell Neurosci 7:65
Janabi N, Peudenier S, Héron B, Ng KH, Tardieu M (1995) Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci Lett 195(2):105–108
Jiang W, Kim BY, Rutka JT, Chan WC (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–150
Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988–994
Kroner A, Greenhalgh AD, Zarruk JG, Passos dos Santos R, Gaestel M, David S (2014) TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 83:1098–1116
Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, Dennis JW (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129:123–134
Lee RT, Lee YC (2000) Affinity enhancement by multivalent lectin–carbohydrate interaction. Glycoconj J 17:543–551
Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F (2004) Introduction to galectins. Glycocon 19:433–440
Louboutin J-P, Strayer D (2014) Role of oxidative stress in HIV-1-associated neurocognitive disorder and protection by Gene delivery of antioxidant enzymes. Antioxidants 3(4):770–797
Lull ME, Block ML (2010) Microglial activation & chronic neurodegeneration. Neurotherapeutics. 7(4):354–365
Lutomski D, Fouillit M, Bourin P, Mellottee D, Denize N, Pontet M, Bladier D, Caron M, Joubert-Caron R (1997) Externalization and binding of galectin-1 on cell surface of K562 cells upon erythroid differentiation. Glycobiology 7:1193–1199
McGraw J, Gaudet AD, Oschipok LW, Kadoya T, Horie H, Steeves JD, Tetzlaff W, Ramer MS (2005) Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons. Exp Neurol 195:103–114
Mercier S, St-Pierre C, Pelletier I, Ouellet M, Tremblay MJ, Sato S (2008) Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology 371:121–129
Miró-Mur F, Pérez-de-Puig I, Ferrer-Ferrer M, Urra X, Justicia C, Chamorro A, Planas AM (2015) Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation. Brain Behav Immun 48:18–33
Morris SM (2007) Arginine metabolism: boundaries of our knowledge. J Nutr 137:1602S–1609S
Munder M (2009) Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 158:638–651
Nath A, Conant K, Chen P, Scott C, Major EO (1999) Transient exposure to HIV-1 tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 274:17098–17102
Nieves CJ Jr, Langkamp-Henken B (2002) Arginine and immunity: a unique perspective. Biomed Pharmacother 56:471–482
Nonaka M, Fukuda M (2012) Galectin-1 for neuroprotection? Immunity 37(2):187–189
Ouellet MS, Pelletier I, Bounou S, Roy J, Hirabayashi J, Sato S, Tremblay MJ (2005) Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J Immunol 174:4120–4126
Ouellet M, St-Pierre C, Tremblay MJ, Sato S (2015) Effect of galectins on viral transmission. Methods Mol Biol 1207:397–420
Parikh NU, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Mammen MJ, Schwartz SA, Mahajan SD (2015) Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity. Brain Res 1624:175–187
Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306:120–124
Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P (2007) Role of arginine metabolism in immunity and immunopathology. Immunobiology 212:795–812
Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA (2009) Arginase-1 expressing macrophages suppress Th2 cytokine driven inflammation and fibrosis. PLoS Pathog 5:e1000371
Qu WS, Wang YH, Ma JF, Tian DS, Zhang Q, Pan DJ, Yu ZY, Xie MJ, Wang JP, Wang W (2011) Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia. J Neurochem 116(2):217–226
Radonić A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313(4):856–862
Rath M, Müller I, Kropf P, Closs EI, Munder M (2014) Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol 5:532
Reynolds JL, Mahajan SD, Sykes D, Nair MP (2006) Heroin-induces differential protein expression by normal human astrocytes (NHA). Am J Infect Dis 2(2):49–57
Reynolds JL, Mahajan SD, Sykes DE, Schwartz SA, Nair MP (2007) Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim Biophys Acta 1774(4):433–442
Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Mammen MJ, Yong KT, Hui R, Prasad PN, Schwartz SA (2012a) Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages. J Immunol 188(8):3757–3765
Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Yong KT, Hui R, Prasad PN, Schwartz SA (2012b) Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages. J NeuroImmune Pharmacol 7(3):673–685
Rezai-Zadeh K, Gate D, Town T (2009) CNS infiltration of peripheral immune cells: D-day for neurodegenerative disease? J NeuroImmune Pharmacol 4(4):462–475. doi:10.1007/s11481-009-9166-2
Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK (2004) Role of microglia in central nervous system infections. Clin Microbiol Rev 17(4):942–964
Rojo AI, McBean G, Cindric M, Egea J, López MG, Rada P, … Cuadrado A (2014) Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal, 21(12):1766–1801
Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775–787. doi:10.1038/nri3086
Sato S, Ouellet M, St-Pierre C, Tremblay MJ (2012) Glycans, galectins, and HIV-1 infection. Ann N Y Acad Sci 1253:133–148
Schnell G, Price RW, Swanstrom R, Spudich S (2010) Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol 84:2395–2407. doi:10.1128/JVI.01863-09
Sonoki T, Nagasaki A, Gotoh T, Takiguchi M, Takeya M, Matsuzaki H, Mori M (1997) Co-induction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J Biol Chem 272:3689–3693
Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez S, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA (2012) Galectin-1 deactivates classically-activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37(2):249–263
St-Pierre C, Ouellet M, Tremblay MJ, Sato S (2010) Galectin-1 and HIV-. Methods Enzymol 480:267–294
St-Pierre C, Ouellet M, Giguère D, Ohtake R, Roy R, Sato S, Tremblay MJ (2012) Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection. Antimicrob Agents Chemother 56(1):154–162
Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S (2015) Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog 11(3):e1004720. doi:10.1371/journal.ppat.1004720
Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53:1181–1194
Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S et al (2012) Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 206:275–282
Wada M, Ono S, Kadoya T, Kawanami T, Kurita K, Kato T (2003) Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosis. J Neurol Sci 208:67–70
Wires ES, Alvarez D, Dobrowolski C, Wang Y, Morales M, Karn J, Harvey BK (2012) Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells. J Neurovirol 18(5):400–410
Zani BG, Bohlen HG (2005) Transport of extracellular l-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide production. Am J Physiol Heart Circ Physiol 289(4):H1381–H1390
Zanon CF, Sonehara NM, Girol AP, Gil CD, Oliani SM (2015) Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation. Mol Vis 21:1036–1050
Zhang N, Deng J, Wu F, Lu X, Huang L, Zhao M (2016) Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV-positive patients. Mol Med Rep 13(1):731–743. doi:10.3892/mmr.2015.4601
Acknowledgements
The authors who like to acknowledge the funding support from the Dr. Louis Sklarow Memorial Trust 2015-2016 (Mahajan SD) and the New York State Department of Health (DOH) funded Empire Clinical Research Investigator Program (ECRIP) (Schwartz SA). The authors are extremely grateful to Dr. Jonathan Karn, Chairman and Reinberger Professor of Molecular Biology, Case Western Reserve University, Cleveland, Ohio and Director of the CASE Center for AIDS Research for the generous donation of the CHME-5/HIV cell line.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
Authors declare no conflict of interests.
Rights and permissions
About this article
Cite this article
Aalinkeel, R., Mangum, C.S., Abou-Jaoude, E. et al. Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 “Nanoplex” a Possible Neurotherapeutic?. J Neuroimmune Pharmacol 12, 133–151 (2017). https://doi.org/10.1007/s11481-016-9723-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-016-9723-4